The Food and Drug Administration March 9 said that the prescription smoking cessation medicine Chantix (varenicline) can change the way people react to alcohol.
In addition, rare accounts of seizures in patients treated with Chantix have been reported, the agency said. The FDA in an online posting said, “We have approved changes to the Chantix label to warn about these risks.”
Until patients know how Chantix affects their ability to tolerate alcohol, they should decrease the amount of alcohol they drink, the FDA said. In addition, patients who have a seizure while taking Chantix should stop the medicine and seek ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.